Loyola Medicine, Gilda's Club Chicago launch new transition program for cancer survivors

NewsGuard 100/100 Score

Loyola Medicine and Gilda's Club Chicago are launching a new program to help cancer survivors make the transition from active treatment to post-treatment care.

The Cancer Transitions program is targeted to patients who have completed treatments within the past 24 months, although the program also can benefit survivors at any time in their survivorship.

Twelve million cancer survivors in the U.S. face heavy physical and psychological burdens as they transition from patients to survivors. The Cancer Support Community and Livestrong Foundation developed Cancer Transitions to address their needs. Gilda's Club Chicago is an affiliate of the Cancer Support Community.

At six Monday sessions, beginning Oct. 20, physicians, nutritionists, fitness trainers and other experts will discuss relaxation and stress management techniques, exercise tailored to your abilities and tips for nutritious eating.

The free workshops will be presented from 6 p.m. to 8 p.m. in the Cardinal Bernardin Cancer Center, 2160 S. First Ave., Maywood. Light refreshments will be served. Here are the topics:

Oct. 20: Get Back to Wellness: Take Control of Your Survivorship

Oct. 27: Exercise for Wellness: Customized Exercise

Nov. 3: Emotional Health and Well-Being: From Patient to Survivor

Nov. 10: Nutrition Beyond Cancer

Nov. 17: Medical Management Beyond Cancer: What You Need to Know

Nov. 24: Life Beyond Cancer

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New AI tool 'TORCH' successfully identifies cancer origins in unknown primary cases